ArticleEMBO molecular medicine2022

A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis.

Richell Booijink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.